###begin article-title 0
LPS Responsiveness and Neutrophil Chemotaxis In Vivo Require PMN MMP-8 Activity
###end article-title 0
###begin p 1
Conceived and designed the experiments: CL CO XP. Performed the experiments: AT JC AC AS RD. Analyzed the data: AT JC. Contributed reagents/materials/analysis tools: CL XP. Wrote the paper: CO AT JC.
###end p 1
###begin p 2
###xml 171 178 171 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 310 311 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 319 321 307 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">79</sup>
###xml 337 339 313 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sup>
###xml 545 549 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 722 729 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 942 946 906 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 994 1001 958 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1195 1196 1159 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1200 1201 1164 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1212 1213 1176 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1217 1218 1181 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 1350 1357 1314 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1417 1423 1381 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cis</italic>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 950 954 <span type="species:ncbi:10090">mice</span>
###xml 1143 1148 <span type="species:ncbi:9606">human</span>
We identify matrix metalloproteinase (MMP)-8, the polymorphonuclear (PMN) leukocyte collagenase, as a critical mediator initiating lipopolysaccharide (LPS)-responsiveness in vivo. PMN infiltration towards LPS is abrogated in Mmp8-null mice. MMP-8 cleaves LPS-induced CXC chemokine (LIX) at Ser4approximatelyVal5 and Lys79approximatelyArg80. LIX bioactivity is increased upon N-terminal cleavage, enhancing intracellular calcium mobilization and chemotaxis upon binding its cognate receptor, CXCR2. As there is no difference in PMN chemotaxis in Mmp8-null mice compared with wild-type mice towards synthetic analogues of MMP-8-cleaved LIX, MMP-8 is not essential for extravasation or cell migration in collagenous matrices in vivo. However, with biochemical redundancy between MMPs 1, 2, 9, and 13, which also cleave LIX at position 4approximately5, it was surprising to observe such a markedly reduced PMN infiltration towards LPS and LIX in Mmp8-/- mice. This lack of physiological redundancy in vivo identifies MMP-8 as a key mediator in the regulation of innate immunity. Comparable results were found with CXCL8/IL-8 and CXCL5/ENA-78, the human orthologues of LIX. MMP-8 cleaves CXCL8 at Arg5-Ser6 and at Val7-Leu8 in CXCL5 to activate respective chemokines. Hence, rather than collagen, these PMN chemoattractants are important MMP-8 substrates in vivo; PMN-derived MMP-8 cleaves and activates LIX to execute an in cis PMN-controlled feed-forward mechanism to orchestrate the initial inflammatory response and promote LPS responsiveness in tissue.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Faurschou1">[1]</xref>
###xml 239 242 239 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Park1">[2]</xref>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Bodey1">[3]</xref>
###xml 435 438 435 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Pizzo1">[4]</xref>
###xml 440 443 440 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Hughes1">[5]</xref>
###xml 718 721 718 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Madri1">[6]</xref>
###xml 856 859 856 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Lillard1">[7]</xref>
###xml 325 333 <span type="species:ncbi:9606">patients</span>
Polymorphonuclear neutrophils (PMNs) are crucial inflammatory leukocytes in host protection from infection, where their primary role is in phagocytosis and killing of bacteria, fungi and protozoa, and in wound debridement and healing [1], [2]. Given these critical roles of PMNs, it has long been recognised that neutropenic patients are at greater risk of infection [3], and that is often observed after intensive cancer chemotherapy [4], [5]. Proteolysis of phagosome contents and damaged extracellular matrix are key PMN actions in inflammation. Cell migration, crossing basement membrane and connective tissue matrix barriers are other aspects of PMN function traditionally thought to require proteolytic activity [6]. Additionally, PMNs are a source of chemotactic factors that guide the recruitment of specific and non-specific immune effector cells [7] and so these first line defence cells play key roles in innate and acquired immunity.
###end p 4
###begin p 5
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Foxman1">[8]</xref>
###xml 256 259 256 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-ClarkLewis1">[9]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Utgaard1">[10]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Malcolm1">[13]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wuyts1">[14]</xref>
###xml 696 700 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-ClarkLewis2">[15]</xref>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Lee1">[16]</xref>
###xml 832 833 832 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1293 1297 1282 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wuyts1">[14]</xref>
###xml 1355 1356 1344 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1500 1504 1489 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wuyts2">[17]</xref>
###xml 1749 1750 1738 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1766 1770 1755 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-ClarkLewis2">[15]</xref>
###xml 1912 1916 1901 1905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban1">[18]</xref>
###xml 1918 1922 1907 1911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban2">[19]</xref>
###xml 1981 1982 1970 1971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2037 2044 2026 2033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 706 712 <span type="species:ncbi:10090">murine</span>
###xml 785 790 <span type="species:ncbi:9606">human</span>
###xml 806 812 <span type="species:ncbi:9606">humans</span>
###xml 1299 1303 <span type="species:ncbi:10090">Mice</span>
###xml 1442 1448 <span type="species:ncbi:10090">murine</span>
Of the two major chemokine subfamilies that provide directional cues for leukocyte migration and activation [8], the CXC chemokines predominantly influence PMNs and T-lymphocytes whereas the CC chemokines are active on monocytes, basophils and eosinophils [9]. The expression of CXC chemokines is rapidly upregulated during acute inflammatory responses, such as that initiated by the endotoxin lipopolysaccaride (LPS) [10]-[13]. A subset of the CXC chemokines are characterised by an ELR (glutamic acid-leucine-arginine) sequence proximal to the conserved CXC motif. ELR is essential for binding CXC-receptors (CXCR) 1 and 2 [14] leading to PMN activation, degranulation and release of proteases [15]. The murine ELR+ CXC chemokines act through a single receptor that is homologous to human CXCR2 [16]. In humans there are seven ELR+ CXC chemokines; CXCL8/interleukin-8 (IL-8); CXCL7/neutrophil-activating peptide-2 (NAP-2); CXCL6/granulocyte chemotactic protein-2 (GCP-2); CXCL5/epithelial cell-derived neutrophil activating peptide-78 (ENA-78); and CXCL1, -2 and -3 (also known as growth-related oncogenes (GRO) alpha, -beta, and -gamma). Only CXCL8/IL-8, the most potent of these chemokines, and CXCL6/GCP-2 bind CXCR1, whereas all members signal through the closely related receptor CXCR2 [14]. Mice lack a homologue of CXCL8/IL-8 having only four ELR+ CXC chemokines: LPS-induced CXC chemokine (LIX), the most abundant and potent of the murine chemokines and regarded as the orthologue of CXCL8 [17]; keratinocyte-derived chemokine (KC); macrophage inflammatory protein-2 (MIP-2); and dendritic cell inflammatory protein-1 (DCIP-1). Physiological N-terminal cleavage of chemokines modifies their bioactivity-either enhancing activity of the ELR+ CXC chemokines [15] or generating potent receptor antagonists from the CC chemokines CCL2, -7, -8 and -13 (also known as macrophage chemotactic proteins 1 to 4) [18], [19]. Although several candidate proteases are proposed for ELR+ CXCL proteolytic activation, none have been validated in vivo.
###end p 5
###begin p 6
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Egeblad1">[20]</xref>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Overall1">[21]</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Tam1">[22]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Dean1">[23]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Parks1">[24]</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban1">[18]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban2">[19]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Dean1">[23]</xref>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban3">[25]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-VanDenSteen1">[27]</xref>
###xml 549 553 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Tam1">[22]</xref>
###xml 555 559 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Gearing1">[28]</xref>
###xml 576 580 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wilson1">[29]</xref>
###xml 609 613 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Butler1">[30]</xref>
###xml 805 809 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Coussens1">[31]</xref>
###xml 901 905 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Acuff1">[32]</xref>
Matrix metalloproteinases (MMPs) are traditionally associated with extracellular matrix protein degradation in many physiological and pathological processes, including inflammation, bacterial infection, wound healing, and cancer cell invasiveness (reviewed in ref [20]). However, it is now clear that MMPs mediate homeostasis of the extracellular environment [21] by modulating the biological activity of many bioactive molecules involved in cell function [22], [23], innate immunity [24] including chemokines [18], [19], [23], [25]-[27], TNF-alpha [22], [28], alpha-defensin [29], and mannose binding lectin [30], and in tumour initiation and progression. Inflammation in cancer, particularly macrophage infiltration and MMP-9 release, generates a microenvironment advantageous to neoplastic progression [31], with recent evidence indicating that a PMN source of MMP-9 can also promote tumorigenesis [32].
###end p 6
###begin p 7
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Weiss1">[33]</xref>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Overall2">[35]</xref>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Overall2">[35]</xref>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
###xml 39 42 <span type="species:ncbi:10116">rat</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
MMP-8 (human: P22894, mouse: CAA73786, rat: AJ007288), the neutrophil collagenase, is produced primarily by PMNs and is released from the specific granules at sites of inflammation [33]. Mmp8-null mice have no overt phenotype, with normal embryonic development, fertility, and long-term survival [34]. In contrast to other MMP deficient mice [35], Mmp8-null mice challenged with carcinogens showed a markedly increased susceptibility to tumorigenesis [34], but this only occurred in male mice. This was the first report of a MMP having a protective role in tumorigenesis, so validating MMP-8 as an anti-target in cancer therapy [35].
###end p 7
###begin p 8
###xml 31 35 31 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Hasty1">[36]</xref>
###xml 37 41 37 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Pelman1">[37]</xref>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 905 909 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-VanLint1">[38]</xref>
###xml 1118 1122 1118 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-VanLint1">[38]</xref>
###xml 1177 1181 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
As a potent type I collagenase [36], [37] it had been predicted that mice lacking the Mmp8 gene would show reduced PMN migration through collagenous matrices [34]. Indeed, at the tumor stromal interface an abnormal inflammatory response is observed, characterised by an initially delayed and then a more diffuse PMN influx in the Mmp8-null mice [34]. However, once established there was a prolonged chronic accumulation of PMNs that did not dissipate. Overall, this phenotype is reversed following transplantation of wild type bone marrow, confirming that the absence of MMP-8 produced by PMNs and not a tissue or tumour source resulted in the higher incidence of tumors. In a model of TNF-induced acute hepatitis, MMP-8 deficient mice showed dampened levels of PMN infiltration into the liver that was postulated to result from reduced LIX mobilization from an unidentified binding protein in the matrix [38]. Together, these studies suggest a coordinating role for MMP-8 in physiological leukocyte trafficking both in acute and chronic inflammation, either through cleavage of collagen or chemokine binding proteins [38], or by processing of bioactive molecules, such as LIX [34] to control PMN migration or longevity.
###end p 8
###begin p 9
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 354 362 354 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 367 374 367 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 528 535 528 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 172 177 <span type="species:ncbi:10090">mouse</span>
###xml 431 436 <span type="species:ncbi:10090">mouse</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 851 854 <span type="species:ncbi:9606">man</span>
Here we have investigated the role of MMP-8 in PMN recruitment during acute inflammation using LPS responsiveness as a trigger; the PMN influx was abrogated in the Mmp8-/- mouse. LIX is identified as a key inflammatory substrate of MMP-8 where N-terminal processing by MMP-8 activates the chemokine and so increases PMN chemotaxis and LPS responsiveness in vitro and in vivo. Although these activities are reduced in the Mmp8-null mouse, the loss of neutrophil collagenolytic activity did not alter in vitro PMN chemokinesis or in vivo chemotaxis when challenged with truncated LIX or truncated CXCL8/IL-8 chemokines. Hence, these data reveal a new auto-regulatory mechanism of PMN chemotaxis that is initiated by MMP-8 release from PMNs and executed, directly or indirectly, by the proteolytic activation of LIX in mice and CXCL8 and CXCL5/ENA-78 in man. This drives further PMN migration in a novel feed-forward mechanism that, remarkably, is a major determinant of LPS responsiveness.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 28 32 <span type="species:ncbi:10090">mice</span>
LPS induced PMN response in mice
###end title 11
###begin p 12
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 299 308 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g001">Figure 1A</xref>
###xml 515 519 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 812 821 810 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g001">Figure 1B</xref>
###xml 913 917 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Owen1">[39]</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
To ascertain the role of MMP-8 in PMN cell migration and LPS responsiveness in vivo we compared Mmp8-/- with Mmp8+/+ mice. The PMN influx was significantly reduced (P</=0.005) when LPS was injected in air pouches formed under the dorsal skin of the MMP-8 knockout mice compared with wild type mice (Figure 1A). This was observed in both male and female mice, although the PMN infiltrate was generally greater in the females towards both LPS and the PBS control. Hence, the reduced PMN migration and accumulation in Mmp8-/- mice reveals a critical role for this PMN-specific protease in neutrophil function in acute inflammation. Notably, MMP-8 was only detected in cell lysates from LPS-treated air pouches of wild type mice, revealing both the pro and active forms of the enzyme at 85 and 65 kDa, respectively (Figure 1B). A 30-kDa inactive degradation product of MMP-8 was also detected, as observed previously [39].
###end p 12
###begin title 13
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 20 26 <span type="species:ncbi:10090">murine</span>
MMP-8 processing of murine ELR+ CXC chemokines
###end title 13
###begin p 14
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 343 352 343 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g002">Figure 2A</xref>
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 806 815 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g002">Figure 2B</xref>
###xml 933 934 921 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 950 951 938 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1090 1092 1078 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">79</sup>
###xml 1209 1218 1197 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g002">Figure 2B</xref>
###xml 1333 1334 1321 1322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 1350 1351 1326 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 174 180 <span type="species:ncbi:10090">murine</span>
We investigated the potential role of MMP-8 to modulate the activity of the cognate ELR+ ligands of CXCR2 that may underlie the defect in LPS-induced PMN migration. The four murine ELR+ CXC chemokines LIX, KC, MIP-2, and DCIP-1 were incubated with recombinant MMP-8. Of these, LIX was the only chemokine susceptible to proteolytic processing (Figure 2A)-KC, MIP-2, and DCIP-1 were MMP-8-resistant even at high enzyme:substrate ratios (1:10) and after prolonged incubation times revealing protease substrate specificity. MALDI-TOF mass spectrometry analysis of the LIX cleavage products showed that MMP-8 processed the chemokine at two sites. The major product of 9,511 Da represents a deletion of the first four NH2-terminal amino acid residues. Edman sequencing confirmed the deconvoluted MALDI-TOF data (Figure 2B). Hence, MMP-8 cleaves the 92-amino acid residue LIX between SerapproximatelyVal at position 4-5 to generate a new NH2-terminus at Val5 that we designate LIX (5-92). With a measured mass of 8,113 Da, the second cleavage product was processed near the COOH-terminus after Lys79, resulting in the removal of 13 amino acid residues and generating the truncated form of LIX designated LIX (5-79) (Figure 2B). LIX (1-79) was never detected. Edman sequencing confirmed the deconvoluted mass spectrometry analysis of the Ser4approximatelyVal5 amino-terminal cleavage site of LIX (5-79).
###end p 14
###begin p 15
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 228 237 228 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g002">Figure 2C</xref>
###xml 312 313 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 389 390 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 482 484 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">75</sup>
###xml 507 509 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">84</sup>
###xml 764 773 752 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g002">Figure 2D</xref>
###xml 841 845 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Overall3">[40]</xref>
###xml 973 977 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban2">[19]</xref>
###xml 1222 1231 1210 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g002">Figure 2D</xref>
###xml 1264 1266 1252 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">79</sup>
###xml 1282 1284 1258 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sup>
###xml 1325 1334 1301 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g002">Figure 2E</xref>
###xml 1414 1416 1390 1392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sup>
###xml 1416 1417 1392 1393 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</bold>
###xml 1423 1424 1399 1400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</bold>
###xml 1429 1431 1405 1407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">92</sup>
As determined by MALDI-TOF mass spectrometry, the NH2- and COOH-terminal processing of LIX was efficient; the cleavage products were first detected by mass spectrometry after 1 h with no full-length chemokine remaining at 18 h (Figure 2C). The COOH-terminal cleavage product was not detected in the absence of NH2-terminal processing at any time point indicating it occurs subsequent to NH2-terminal cleavage. Although the C-terminal cleavage was at an unusual highly cationic site 75KKKAKapproximatelyRNALA84 it was confirmed to be MMP dependent as two MMP inhibitors, EDTA and the synthetic hydroxamate small molecule chemical inhibitor BB94, blocked all LIX processing with no cleavage products detected by MALDI-TOF mass spectrometry or Tris-tricine SDS-PAGE (Figure 2D). Chemokine cleavage is often enhanced by MMP exosite interactions [40]. For instance, the hemopexin C domain of MMP-2 greatly increases the catalytic rate constants of CCL2, -7, -8 and -13 cleavage [19]. When molar excess of recombinant MMP-8 hemopexin C-domain was added in the cleavage assays, we likewise found that all LIX processing by MMP-8 was abrogated revealing that a binding site for LIX was present on the hemopexin C domain of MMP-8 (Figure 2D). The C-terminal cleavage at Lys79approximatelyArg80 only slightly reduced heparin affinity (Figure 2E) consistent with the removal of just two basic residues in the cleaved peptide 80RNALAVERTASVQ92 while the N-terminal truncation had no effect on heparin binding.
###end p 15
###begin title 16
Processing of LIX by other MMPs
###end title 16
###begin p 17
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 131 132 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 134 142 122 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g003">Figure 3</xref>
###xml 268 269 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 285 286 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 288 296 264 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g003">Figure 3</xref>
###xml 440 444 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban3">[25]</xref>
###xml 474 478 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban2">[19]</xref>
###xml 643 652 619 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g003">Figure 3A</xref>
###xml 717 719 693 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">79</sup>
###xml 735 737 699 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sup>
Proteolytic screening of LIX cleavage by several MMPs showed that MMP-9, a prominent PMN MMP, processed LIX at Ser4approximatelyVal5 (Figure 3). In addition to MMP-9, other important stromal, endothelial and leukocytic MMPs 1, -2, and -13 could also process LIX at Ser4approximatelyVal5 (Figure 3), but like MMP-8, did not cleave KC, MIP-2, or DCIP-1 (not shown). Similar redundancy has been shown with MMPs for CXCL12 (also know as SDF-1) [25] and for CCL2, -7, -8 and -13 [19]. Protease selectivity was also shown with MMP-14, the RNA of which is also expressed by PMNs (data not shown), but was incapable of processing LIX at any position (Figure 3A). Further, only MMP-8 could process the C-terminus of LIX at Lys79approximatelyArg80.
###end p 17
###begin title 18
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Effect of LIX processing on in vitro biological activity
###end title 18
###begin p 19
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 288 290 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 339 348 327 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g004">Figure 4A</xref>
###xml 383 387 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 435 437 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 518 527 506 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g004">Figure 4B</xref>
###xml 706 715 694 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g004">Figure 4C</xref>
###xml 744 748 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 797 806 785 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g004">Figure 4D</xref>
###xml 837 841 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 908 912 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 922 931 910 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g004">Figure 4D</xref>
###xml 1070 1078 1058 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 125 131 <span type="species:ncbi:10090">murine</span>
###xml 376 382 <span type="species:ncbi:10090">murine</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
Upon binding to the receptor CXCR2, LIX mobilizes intracellular Ca++ ion stores. As measured in recombinant CXCR2-expressing murine pre-B 300-19 cells, synthetic analogues of the MMP-truncated forms of LIX (5-92) and LIX (5-79) both induced an approximately2-fold greater intracellular Ca++ ion release compared to full-length LIX (1-92) (Figure 4A). This was confirmed using murine Mmp8-/- PMNs where an even greater stimulation in Ca++ ion release was observed upon binding LIX (5-92) compared with full-length LIX (Figure 4B). Functionally, this translated into enhanced chemoattraction for the CXCR2-expressing pre-B 300-19 cells by both of the truncated forms of LIX versus the full-length chemokine (Figure 4C), and in purified PMNs from Mmp8+/+ mice compared to the unprocessed LIX (1-92) (Figure 4D). Notably, PMNs isolated from Mmp8-/- mice migrated towards LIX (5-92) in a comparable manner to the Mmp8+/+ PMNs (Figure 4D and data not shown) indicating that the locomotor functions of PMNs isolated from both wild type and MMP-8 knock out mice were equivalent in vitro and unaffected by the presence or absence of MMP-8.
###end p 19
###begin title 20
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo PMN chemotaxis towards LIX
###end title 20
###begin p 21
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 283 291 271 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g005">Figure 5</xref>
###xml 481 489 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g005">Figure 5</xref>
###xml 598 605 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 772 780 760 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
Infiltration of PMNs towards LIX (1-92) injected in a dorsal skin air pouch of Mmp8-/- mice was impaired at all time points compared to PMN infiltration in wild type mice, with an approximately2-fold lower number of PMNs seen at 8 and 12 h in knock out compared with wild type mice (Figure 5). In contrast, when LIX (5-92) or LIX (5-79) were used as chemoattractants there was no significant difference in PMN infiltration into the air pouches of wild type and mice lacking MMP-8 (Figure 5). This indicates that MMP-8 activity is not essential for blood vessel extravasation and PMN cell migration in vivo and that there is little physiological redundancy by PMN MMP-9, or from tissue MMPs that we found competent in cleaving and activating LIX in the biochemical context in vitro.
###end p 21
###begin title 22
MMP-8 processes and activates IL-8 and ENA-78
###end title 22
###begin p 23
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 479 480 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 711 712 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 749 750 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 766 767 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 794 806 771 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g006">Figure 6A, C</xref>
###xml 840 841 817 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 857 858 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 885 894 850 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g006">Figure 6C</xref>
###xml 1135 1144 1100 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g006">Figure 6B</xref>
###xml 402 405 <span type="species:ncbi:9606">man</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
###xml 973 979 <span type="species:ncbi:10090">murine</span>
Our experimental data suggest that upon LPS-induced release of LIX and resultant PMN chemoattraction a feed-forward PMN activation mechanism operates in vivo. MMP-8 released from degranulating PMNs at the site of challenge fully activates LIX in the tissue to further enhance PMN migration towards the LPS stimulus. To ascertain whether a similar autologous CXCR2 ligand activation mechanism occurs in man we assessed every human CXCR2 ligand for MMP-8 cleavage. Of the seven ELR+ CXC chemokines (CXCL8/IL-8, CXCL7/NAP-2, CXCL6/GCP-2, CXCL5/ENA-78, CXCL3/GROgamma, CXCL2/GRObeta and CXCL1/GROalpha) only CXCL8 and CXCL5 were processed by MMP-8. By MALDI-TOF MS and confirmation by Edman sequencing, CXCL8 was NH2-terminally processed by MMP-8 at Arg5approximatelySer6 to generate CXCL8 (6-77) (Figure 6A, C) whereas CXCL5 was cleaved at Val7approximatelyLeu8 to generate CXCL5 (8-78) (Figure 6C). There were no COOH-terminal cleavages detected. Another difference from the murine system was that CXCL8 cleavage was not hemopexin C domain dependent-proteolysis was not inhibited in the presence of a molar excess of hemopexin C domain (Figure 6B).
###end p 23
###begin p 24
###xml 262 263 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 291 300 291 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g006">Figure 6D</xref>
###xml 398 402 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-ClarkLewis2">[15]</xref>
###xml 404 408 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-VandenSteen1">[26]</xref>
###xml 410 414 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-VanDenSteen1">[27]</xref>
###xml 574 576 570 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 591 600 587 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g007">Figure 7A</xref>
###xml 648 656 644 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 658 667 654 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g007">Figure 7B</xref>
###xml 865 869 861 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 879 888 875 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g007">Figure 7C</xref>
###xml 1091 1095 1087 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 1147 1154 1143 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1286 1295 1282 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g007">Figure 7C</xref>
###xml 1799 1811 1795 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g006">Figure 6A, D</xref>
###xml 1862 1863 1858 1859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 1879 1881 1863 1865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1914 1915 1898 1899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1931 1932 1903 1904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 1934 1943 1906 1915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000312-g006">Figure 6D</xref>
###xml 1959 1967 1931 1939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1972 1979 1944 1951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 974 978 <span type="species:ncbi:10090">mice</span>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
###xml 1668 1673 <span type="species:ncbi:9606">human</span>
###xml 1690 1696 <span type="species:ncbi:10090">murine</span>
###xml 1786 1791 <span type="species:ncbi:9606">human</span>
###xml 1844 1849 <span type="species:ncbi:9606">human</span>
###xml 2053 2057 <span type="species:ncbi:10090">mice</span>
###xml 2059 2064 <span type="species:ncbi:9606">human</span>
To determine protease specificity, other MMPs were screened for cleavage of CXCL5 and CXCL8. Only MMP-1 and MMP-8 cleaved CXCL5, with MMPs 1, 8, 9, 13 and 14 cleaving CXCL8. Some differences in cleavage site specificity were identified, but all cleavages were NH2-terminal to the ELR motif (Figure 6D) and none cut in the C-terminal alpha-helix, as occurs for LIX. Consistent with previous studies [15], [26], [27] and our results with MMP-8 cleavage of LIX, MMP-8 processing of CXCL8 markedly activated the chemokine, with CXCL8 (6-77) leading to increased intracellular Ca++ mobilization (Figure 7A) and commensurate cell migration in transwells in vitro (Figure 7B). Despite several MMPs biochemically characterised to cleave and activate CXCL8, the critical importance of MMP-8 in CXCL8 activation was shown by injecting full-length CXCL8 in the air pouches of Mmp8-/- mice (Figure 7C). Here, the early PMN migration was decreased by >50% at 4 h compared with wild type mice. At later time points, there was less of a difference, but still it was always depressed in the knock out mice. Mmp8-/- PMN responsiveness and cell migratory behaviour in vivo was also shown to be unaffected by the absence of MMP-8 when challenged with the synthetic analogue of MMP-8-cleaved CXCL8 (6-77) (Figure 7C). This reconfirms the critical role of MMP-8 in directing chemotaxis by chemokine processing rather than cleavage of other molecules such as those in the blood vessel wall or extracellular matrix. Similar results were obtained using synthetic analogues of MMP-8-cleaved CXCL5 (8-78) compared with full-length CXCL5 (1-78) in the air pouch model (data not shown). In using human chemokines in a murine setting, it was important to show that rodent MMP-8 did cleave CXCL8 at the same site as human MMP-8 (Figure 6A, D). However, rodent MMP-8 cleaved human CXCL5 at Arg9approximatelyGlu10 with no cleavage detected at Val7approximatelyLeu8 (Figure 6D). Hence, these in vitro and in vivo studies indicate that similar to PMN migration mechanisms towards LIX in mice, human PMN chemoattraction in response to CXCL8 and CXCL5 also exhibits a unique MMP-8 dependent feed-forward activation mechanism.
###end p 24
###begin title 25
Discussion
###end title 25
###begin p 26
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 326 333 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 613 614 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 690 697 690 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 180 186 <span type="species:ncbi:10090">murine</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
We have addressed the role of MMPs in the activation of ELR+ CXC chemokines in vivo. Using Mmp8-/- mice, the essential role of PMN MMP-8 was shown in the activation pathway of the murine CXC chemokine LIX and human CXCL5 and CXCL8. Reflecting this, the absence of MMP-8 led to a profoundly defective PMN infiltration response in vivo to LPS or to full-length LIX, CXCL8, and CXCL5. This occurred despite the biochemical redundancy in chemokine activation by several commonly expressed MMPs including 1, 2, 9, 13, and 14 in a chemokine specific manner. PMN MMP-8 proteolysis leads to the activation of selected ELR+ CXC chemokines responsible for directing PMN cell migration and activation in vivo. With MMP-8 being primarily expressed by PMNs, our study identifies MMP-8 as an essential mediator of an interesting and unique activation mechanism of PMNs in innate immunity. This highlights an unexpectedly important role of the PMN itself in the integration of stimuli for the appropriate release of MMP-8 for LIX, CXCL8, and CXCL5 activation and so reveals an autologous cellular activation mechanism that acts in a feed-forward manner to orchestrate the PMN influx and LPS responsiveness.
###end p 26
###begin p 27
###xml 317 318 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-ClarkLewis2">[15]</xref>
###xml 692 699 692 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 855 856 855 856 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 888 889 888 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wuyts2">[17]</xref>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wuyts3">[41]</xref>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-VanDamme1">[42]</xref>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wuyts4">[43]</xref>
###xml 1035 1042 1035 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1068 1072 1068 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Betsuyaku1">[44]</xref>
###xml 1094 1098 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Belaaouaj1">[45]</xref>
###xml 1135 1139 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Allport1">[46]</xref>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-MacIvor1">[47]</xref>
###xml 1328 1335 1328 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1397 1401 1397 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 1535 1542 1535 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1044 1048 <span type="species:ncbi:10090">Mice</span>
###xml 1405 1410 <span type="species:ncbi:10090">mouse</span>
Precise control of innate immunity is key for the development of successful inflammatory responses, resolution of infection, tissue healing, and ultimately host survival. As first line defence cells, the rapid recruitment and efficient activation of PMNs is of critical importance. It has long been known that the ELR+ CXCR2 cognate ligands that direct PMN chemotaxis and activation are expressed as relatively inactive ligands requiring proteolytic truncation of up to eight amino acid residues from the amino terminus for full activity, providing that the essential ELR motif remains intact [15]. However, relatively little attention has been focused on identifying the responsible enzymes in vivo and the location of chemokine activation-key questions for understanding the control of PMN function and innate immunity mechanisms. Naturally occurring NH2-terminal truncated forms of ELR+ CXC chemokines including LIX [17], [41], CXCL8 [42], CXCL1, 3 and 5 [43], have been reported but the proteases involved have not been identified in vivo. Mice deficient in MMP-9 [44], neutrophil elastase [45], both MMP-9 and neutrophil elastase [46], or cathepsin G [47] exhibit a normal PMN chemotactic response, indicating that PMNs neither require these enzymes for CXC chemokine activation, nor for migration and efficient chemotaxis in vivo. Hence, the deficient LPS and PMN migratory responses in the Mmp8-/- mouse are unique and reveal the singular importance of MMP-8 in these processes. However, we do not discount the possibility that in vivo other proteases downstream of MMP-8 activity may also activate LIX.
###end p 27
###begin p 28
###xml 38 42 38 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-ClarkLewis2">[15]</xref>
###xml 44 48 44 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Wuyts3">[41]</xref>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">79</sup>
###xml 424 426 412 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">80</sup>
###xml 723 727 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Rot1">[48]</xref>
###xml 792 796 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Proudfoot1">[49]</xref>
###xml 811 812 799 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 828 832 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Li1">[50]</xref>
###xml 932 936 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Perrimon1">[51]</xref>
###xml 801 807 <span type="species:ncbi:10090">murine</span>
Consistent with previous observations [15], [34], [41] was our demonstration through the use of in vitro calcium flux and chemotaxis assays that the MMP-8-processed chemokine products LIX (5-92), LIX (5-79), CXCL8 (6-77), and CXCL5 (8-78) were more potent than the full-length chemokines. Notably, LIX (5-92) and (5-79) were equally potent chemokines indicating that the C-terminal cleavage at position Lys79approximatelyArg80 did not influence chemotactic activity. Chemokines interact with the highly negatively charged glycosaminoglycan chains of proteoglycans resulting in immobilization and the generation of a haptotactic gradient within the extracellular matrix that is responsible for directing leukocyte migration [48]. This has been confirmed physiologically for CC type chemokines [49] and murine ELR+ CXC chemokines [50]. Binding is typically through a heparin binding consensus sequence BBXB where B is a basic residue [51]. The MMP-8 C-terminal cleavage of LIX only removes two basic amino acids, both arginines, in the truncated product and so only slightly reduces heparin affinity. The biological significance of this cleavage is therefore unknown.
###end p 28
###begin p 29
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 361 362 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 407 408 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 424 426 400 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 523 526 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">187</sup>
###xml 531 532 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 548 551 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">187</sup>
###xml 605 608 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">187</sup>
###xml 629 630 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 642 643 618 619 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 648 650 624 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 694 695 670 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 711 713 675 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 748 749 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 765 766 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 776 778 728 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 802 803 754 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 855 858 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">187</sup>
###xml 918 922 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Smith1">[52]</xref>
###xml 993 994 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1059 1067 1011 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1179 1186 1131 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1220 1224 1172 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
###xml 447 453 <span type="species:ncbi:10090">murine</span>
###xml 458 461 <span type="species:ncbi:10116">rat</span>
###xml 489 494 <span type="species:ncbi:9606">human</span>
###xml 564 569 <span type="species:ncbi:9606">human</span>
###xml 984 989 <span type="species:ncbi:9606">human</span>
###xml 1162 1167 <span type="species:ncbi:9606">human</span>
###xml 1228 1232 <span type="species:ncbi:10090">mice</span>
None of the MMPs analysed could cleave any of the other murine ELR+ chemokines (data not shown) revealing the specificity of MMP chemokine cleavage. This susceptibility of LIX to MMP processing is likely due to an extended N-terminus before the ELR motif, as compared with KC, MIP-2, and DCIP-1. Interestingly, rodent MMP-8 cleaved CXCL5 at Val7approximatelyLeu8 and not at the same site as human MMP-8, Arg9approximatelyGlu10. The active site of murine and rat MMP-8 differs from that of human MMP-8 by the presence of Lys187 at S3' instead of Ala187 as found in human MMP-8. Charge repulsion between Lys187 in rodent MMP-8 at S3' with the P3' Arg12 in CXCL5 may preclude CXCL5 cleavage at Arg9approximatelyGlu10 and instead favour cleavage at Val7approximatelyLeu8. Here Glu10 of CXCL5 would be the P3' residue and so likely forms a salt bridge with Lys187. Although LIX shows structural homology to CXCL5 and CXCL6 [52], MMP-8 exclusively cleaved CXCL5 and CXCL8 amongst all seven human ELR+ CXC chemokines. The activation of CXCL5 and CXCL8 were shown by in vitro calcium flux and chemotaxis assays, with the singular importance of MMP-8 in activating these human chemokines in vivo shown from studies comparing the Mmp8-/- mice with the wild type controls.
###end p 29
###begin p 30
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 730 737 730 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 994 998 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Egeblad1">[20]</xref>
###xml 1000 1004 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Coussens2">[53]</xref>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Dvorak1">[54]</xref>
###xml 1268 1272 1268 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 1664 1668 1664 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 1734 1738 1734 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Overall2">[35]</xref>
###xml 1795 1799 1795 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McCawley1">[55]</xref>
###xml 1858 1862 1858 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Houghton1">[56]</xref>
###xml 1274 1278 <span type="species:ncbi:10090">Mice</span>
###xml 2210 2214 <span type="species:ncbi:10090">mice</span>
Our results reveal that chemokine processing is one of the most important functions of MMP-8 in vivo and casts into doubt the importance of MMP-8 in collagen degradation, a role that has long been assumed to be of particular importance for PMN cell migration and chemotaxis. Indeed, using air pouch models, no difference in PMN cell migration and infiltration was observed in response to synthetic analogues of the MMP-8 cleaved LIX, CXCL8, and CXCL5. This shows that the PMN cell migration machinery to chemotactic agents does not require MMP-8 activity for responsiveness and that MMP-8 proteolysis of blood vessel basement membrane and interstitial extracellular matrix components is not essential for effective cell migration in vivo. Although MMPs have traditionally been thought to cleave extracellular matrix components and so disrupt extracellular matrix contacts with the tumour and potentiate tumour cell spread and metastasis, other biological roles for MMPs in cancer are now known [20], [53]. Potentially related to this, sustained inflammatory responses maintain a microenvironment advantageous to tumour growth [54]. Indeed, MMP-8 modulates the innate immune response induced by carcinogens leading to a protective role in preventing tumour progression [34]. Mice lacking MMP-8 exhibited an abnormal inflammatory response upon application of carcinogen, with a delayed and more diffuse PMN influx to the site of the host challenge. Once established though, the inflammatory response was sustained and the mechanism for this is under investigation in our laboratory. With MMP-8 being the first MMP reported to have a protective role in tumorigenesis [34], the recognition of further MMP anti-targets in cancer continues [35]. MMP-3 has a protective role in squamous cell carcinoma [55] and macrophage MMP-12 is an anti-target in lung carcinoma [56]. In these cases the proteases were reported to alter leukocyte infiltration, although the mechanism and substrates were not elucidated. In view of the considerable number of chemokines now known to be processed by MMPs, chemokines are strong candidate substrates to phenotypically explain cancer anti-target activity in these MMP genetic knockout mice.
###end p 30
###begin p 31
###xml 287 295 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 300 307 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban1">[18]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban2">[19]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban3">[25]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Zhang1">[57]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Vergote1">[58]</xref>
###xml 672 674 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">71</sup>
###xml 690 692 678 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">72</sup>
###xml 692 696 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Dean1">[23]</xref>
###xml 813 814 801 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 830 831 806 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1003 1009 979 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cis</italic>
###xml 473 476 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1203 1208 <span type="species:ncbi:10090">mouse</span>
###xml 1233 1236 <span type="species:ncbi:9606">man</span>
The role of MMPs in LPS responsiveness and PMN migration differs from that found for macrophages and CXCR4-displaying leukocytes. Instead of promoting cell migration, MMP cleavage of CC chemokines CCL2, -7, -8 and -13 results in the loss of agonist activity and the generation of potent in vitro and in vivo CCR antagonists [18], [19]. Interestingly, the MMP-2 cleavage and inactivation of CXCL12 [25] in the brain generates a potent and selective neurotoxin implicated in HIV dementia [57], [58]. We also recently found that MMP-2 induces the shedding of the integral plasma membrane chemokine CX3CL1 (fractalkine) by release of the chemokine domain from the stalk at Ala71approximatelyLeu72[23]. Further, the cell surface agonist activity of CX3CL1 was converted to a soluble antagonist due to processing at Gly4approximatelyMet5. Hence, MMPs dynamically regulate the biological activity of chemokines and inflammatory and immune cell function in pleiotropic ways. Our present studies suggest that an in cis feed-forward activation mechanism occurs in which the PMN integrates the tissue signalling milieu leading to controlled release of MMP-8 that either directly or indirectly activates LIX in the mouse, and CXCL8 and CXCL5 in man for further PMN migration.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
Animals
###end title 33
###begin p 34
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
Mice deficient in Mmp8 on a C57BL6/Jx129 S background were provided by Dr. S. Shapiro (Boston, USA). Wild type C57BL6/Jx129 S mice were purchased from the Jackson Laboratory. Animal breeding and experimental procedures were approved by the Animal Care Committee of the University of British Columbia. 6-8 week old mice, segregated according to sex, were used for all experiments.
###end p 34
###begin title 35
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo PMN chemotaxis
###end title 35
###begin p 36
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Edwards1">[59]</xref>
###xml 607 611 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Tateda1">[60]</xref>
###xml 801 805 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Balbin1">[34]</xref>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 758 764 <span type="species:ncbi:9986">rabbit</span>
###xml 789 794 <span type="species:ncbi:10090">mouse</span>
The air pouch model of PMN chemotaxis was used as described previously [59]. Sterile air (3 mL) was injected under the dorsal skin of mice, two days later the air pouch was reinflated with 2 mL of sterile air. On day five, 1 microg LPS (Sigma) in phosphate buffered saline or 5 microg of chemokine in 1 mL 0.5% carboxymethylcellulose was injected into the air pouch. After 0, 4, 8, or 12 h the mice were sacrificed and air pouches lavaged with 2 mL of sterile PBS. The resulting cell suspensions were lysed with 0.1% Triton-X100 and freeze-thawed. The PMN content was determined by myeloperoxidase activity [60] using isolated PMN cells as a standard. Cell lysate aliquots were separated by 7.5% SDS-PAGE and MMP-8 was detected by western blot with 1:10,000 rabbit IgG against recombinant mouse MMP-8 [34].
###end p 36
###begin title 37
Chemokines and proteinases
###end title 37
###begin p 38
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-ClarkLewis3">[61]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban1">[18]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-McQuibban2">[19]</xref>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
LIX (1-92), LIX (5-92), LIX (5-79), MIP-2, KC, DCIP-1, CXCL8, CXCL8 (6-77), CXCL5 and CXCL5 (8-78) were chemically synthesized and purified [61]. Recombinant human MMP-1, -2, -8, -9, -13, -14, rodent MMP-8, -13, and recombinant human MMP-8 hemopexin C-domain were expressed and purified [18], [19]. The synthetic hydroxamate MMP inhibitor Batimastat (BB94) was from British Biotech (Oxford, UK).
###end p 38
###begin title 39
Chemokine cleavage assays
###end title 39
###begin p 40
###xml 175 176 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 510 511 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Analysis of chemokine cleavage by MMPs was performed at enzyme/chemokine ratios from 1:1000 up to 1:10 (w/w), at 37degreesC in assay buffer (150 mM NaCl, 20 mM Tris, 5 mM CaCl2, pH 7.5) in the presence of 1 mM APMA to activate proMMPs for 16-22 h. Digests were terminated by adding 5 microM EDTA. Recombinant MMP-8 hemopexin C-domain, EDTA or BB94 were added to cleavage assays as indicated. Reaction products were analyzed by 15% Tris-Tricine SDS-PAGE and stained with Coomassie Brilliant Blue R250. The [M+H]+/z of each cleavage product was determined by matrix assisted laser desorption ionization time of flight (MALDI-TOF) mass spectrometry on a Voyager-DEtrade mark STR Biospectrometry Workstation (ABI). Mass spectrometry data was deconvoluted to identify the substrate cleavage sites and confirmed by Edman sequencing.
###end p 40
###begin title 41
Heparin binding
###end title 41
###begin p 42
###xml 162 164 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
To assess the effect of MMP truncations of LIX on heparin binding, 0.5 mL of 4 microM chemokine in 10 mM potassium phosphate, pH 7.5 was loaded onto a 1 mL HitrapTM heparin-Sepharose column (GE Healthcare). Bound LIX and synthetic analogues of MMP-cleaved LIX were eluted using a linear gradient of 0 to 1.0 M NaCl over 20 min at a flow rate of 1.0 mL/min and monitored by in-line absorbance at 215 nm.
###end p 42
###begin title 43
Cells
###end title 43
###begin p 44
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000312-Allport1">[46]</xref>
###xml 460 462 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 254 260 <span type="species:ncbi:10090">murine</span>
###xml 302 307 <span type="species:ncbi:9606">human</span>
###xml 425 431 <span type="species:ncbi:9913">bovine</span>
Murine PMNs were isolated from bone marrow as previously described [46] except PMNs were recovered from a density gradient comprised of Histopaque 1077 layered on top of Histopaque 1119 according to manufacture's instructions (Sigma, St Louis, USA). The murine pre-B 300-19 cell line stably expressing human CXCR2 was supplied by Dr. B. Moser (Bern, Switzerland). Cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum, 1% glutamine and 5x10-5 M beta-mercaptoethanol (Sigma) under puromycin (1.5 microg/mL) selection.
###end p 44
###begin title 45
Measurement of intracellular calcium mobilization
###end title 45
###begin p 46
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 276 277 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 680 682 660 662 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine PMNs or CXCR2-transfected B300-19 cells (1x107/mL in RPMI-1640 media supplemented with 1% serum) were incubated with 2 microM Fluo-4-acetoxymethyl ester (Molecular Probes), for 30 min, 37degreesC. Cells were washed to remove unincorporated agent and resuspended at 1x106 cells/mL in Hanks Balanced Salt Solution (Gibco), 20 mM HEPES, 2.5 mM probenecid (Sigma). The cells were allowed to equilibrate at 37degreesC for 5 min prior to addition of ligand as indicated. Calcium concentration was monitored by excitation at 485 nm and emission of 520 nm with a PerkinElmer LS50B spectrophotometer. Calibration was performed by addition of 5 microM ionomycin (Sigma) and 1 mM MnCl2 (Fisher Biotech).
###end p 46
###begin title 47
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro chemotaxis assays
###end title 47
###begin p 48
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 33 39 <span type="species:ncbi:10090">murine</span>
###xml 147 153 <span type="species:ncbi:9913">bovine</span>
###xml 434 440 <span type="species:ncbi:10090">murine</span>
Murine PMNs or CXCR2-transfected murine pre-B cells were plated (1x106/well in alphaMEM, 0.1% BSA) in transwell inserts (pre-coated with 10% fetal bovine serum) containing 3 microm or 8 microm pores respectively (Costar). Chemokines were added to the lower chamber and the plates incubated at 37degreesC. PMN chemotaxis assays were performed for 1 h. The migrated cells were then fixed with 4% paraformaldehyde prior to counting. The murine pre-B cell transfectants were assayed for 4 h after which the migrated cells were counted.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
Neutrophil granules and secretory vesicles in inflammation.
###end article-title 50
###begin article-title 51
Understanding the role of immune regulation in wound healing.
###end article-title 51
###begin article-title 52
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.
###end article-title 52
###begin article-title 53
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Management of fever in patients with cancer and treatment-induced neutropenia.
###end article-title 53
###begin article-title 54
###xml 67 75 <span type="species:ncbi:9606">patients</span>
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.
###end article-title 54
###begin article-title 55
Cell migration in the immune system: the evolving inter-related roles of adhesion molecules and proteinases.
###end article-title 55
###begin article-title 56
Mechanisms for induction of acquired host immunity by neutrophil peptide defensins.
###end article-title 56
###begin article-title 57
Multistep navigation and the combinatorial control of leukocyte chemotaxis.
###end article-title 57
###begin article-title 58
Structure-activity relationships of chemokines.
###end article-title 58
###begin article-title 59
Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells.
###end article-title 59
###begin article-title 60
###xml 82 88 <span type="species:ncbi:9606">humans</span>
Induction of cell-associated chemokines after endotoxin administration to healthy humans.
###end article-title 60
###begin article-title 61
Lipopolysaccharide-induced neutrophil gene expression under in vivo or in vitro conditions.
###end article-title 61
###begin article-title 62
###xml 50 55 <span type="species:ncbi:9606">human</span>
Microarray analysis of lipopolysaccharide-treated human neutrophils.
###end article-title 62
###begin article-title 63
Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
###end article-title 63
###begin article-title 64
Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.
###end article-title 64
###begin article-title 65
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Chemokine binding and activities mediated by the mouse IL-8 receptor.
###end article-title 65
###begin article-title 66
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2.
###end article-title 66
###begin article-title 67
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
###end article-title 67
###begin article-title 68
Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.
###end article-title 68
###begin article-title 69
New functions for the matrix metalloproteinases in cancer progression.
###end article-title 69
###begin article-title 70
Dilating the degradome: matrix metalloproteinase 2 (MMP-2) cuts to the heart of the matter.
###end article-title 70
###begin article-title 71
Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates.
###end article-title 71
###begin article-title 72
Proteomic discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome.
###end article-title 72
###begin article-title 73
Matrix metalloproteinases as modulators of inflammation and innate immunity.
###end article-title 73
###begin article-title 74
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1.
###end article-title 74
###begin article-title 75
Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.
###end article-title 75
###begin article-title 76
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.
###end article-title 76
###begin article-title 77
Processing of tumour necrosis factor-alpha precursor by metalloproteinases.
###end article-title 77
###begin article-title 78
Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.
###end article-title 78
###begin article-title 79
###xml 112 117 <span type="species:ncbi:9606">human</span>
Mannose-binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis: potential role in human MBL deficiency.
###end article-title 79
###begin article-title 80
Inflammation and cancer.
###end article-title 80
###begin article-title 81
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
###end article-title 81
###begin article-title 82
###xml 50 55 <span type="species:ncbi:9606">human</span>
Oxidative autoactivation of latent collagenase by human neutrophils.
###end article-title 82
###begin article-title 83
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice.
###end article-title 83
###begin article-title 84
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
###end article-title 84
###begin article-title 85
###xml 38 43 <span type="species:ncbi:9606">human</span>
The collagen substrate specificity of human neutrophil collagenase.
###end article-title 85
###begin article-title 86
Pivotal molecular determinants of peptidic and collagen triple helicase activities reside in the S3' subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond.
###end article-title 86
###begin article-title 87
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis.
###end article-title 87
###begin article-title 88
Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase.
###end article-title 88
###begin article-title 89
Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics.
###end article-title 89
###begin article-title 90
###xml 38 44 <span type="species:ncbi:10090">murine</span>
NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
###end article-title 90
###begin article-title 91
The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
###end article-title 91
###begin article-title 92
Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.
###end article-title 92
###begin article-title 93
Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B.
###end article-title 93
###begin article-title 94
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis.
###end article-title 94
###begin article-title 95
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro.
###end article-title 95
###begin article-title 96
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Normal neutrophil function in cathepsin G-deficient mice.
###end article-title 96
###begin article-title 97
Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism.
###end article-title 97
###begin article-title 98
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
###end article-title 98
###begin article-title 99
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.
###end article-title 99
###begin article-title 100
Specificities of heparan sulphate proteoglycans in developmental processes.
###end article-title 100
###begin article-title 101
###xml 65 71 <span type="species:ncbi:10090">murine</span>
Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines.
###end article-title 101
###begin article-title 102
Matrix metalloproteinases and the development of cancer.
###end article-title 102
###begin article-title 103
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
###end article-title 103
###begin article-title 104
A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.
###end article-title 104
###begin article-title 105
Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases.
###end article-title 105
###begin article-title 106
###xml 85 88 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Metalloproteinase Cleavage of the Chemokine SDF-1alpha Induces Neuronal Apoptosis in HIV Encephalitis.
###end article-title 106
###begin article-title 107
###xml 88 91 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration.
###end article-title 107
###begin article-title 108
The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system.
###end article-title 108
###begin article-title 109
###xml 48 54 <span type="species:ncbi:10090">murine</span>
Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells.
###end article-title 109
###begin article-title 110
Chemical synthesis, purification, and folding of C-X-C and C-C chemokines.
###end article-title 110
###begin title 111
Figures and Tables
###end title 111
###begin title 112
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Impaired PMN responsiveness to LPS in MMP-8 deficient mice.
###end title 112
###begin p 113
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 150 154 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 351 357 <span type="species:ncbi:10090">murine</span>
(A) Infiltration of PMNs in vivo in response 1 microg of LPS (n = 8) or phosphate buffered saline control (n = 4) injected into the air pouch of male Mmp8-/- (black bar) and wild type mice (white bar) was assessed 8 h post-injection. The PMN influx was quantitated by myeloperoxidase activity. Error bars, standard error. (B) Western blot analysis of murine MMP-8 in LPS-treated air pouch PMN lysates corresponding to 50,000 cells per lane.
###end p 113
###begin title 114
MMP-8 Cleavage of LIX.
###end title 114
###begin p 115
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n.d.</italic>
###xml 566 574 566 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP-8 CD</italic>
###xml 64 70 <span type="species:ncbi:10090">murine</span>
(A) Tris-tricine 15% SDS-PAGE gel analysis of MMP-8 cleavage of murine CXCR2-binding chemokines DCIP-1, KC, LIX and MIP-2. The m/z [M+H]+ of reaction products are as shown. (B) Identification of cleavage products by MALDI-TOF mass spectrometry and NH2-terminal Edman sequencing. n.d., not determined. (C) Tris-tricine 15% SDS-PAGE and MALDI-TOF analysis of LIX cleavage products generated over time (h) by MMP-8. (D) Tris-tricine 15% SDS-PAGE and MALDI-TOF analysis of LIX cleavage by MMP-8 in the presence of 10-fold molar excess of recombinant hemopexin C-domain (MMP-8 CD), 10 microM EDTA, or 10 microM BB94. (E) Heparin Sepharose AKTA chromatograms of synthetic analogues of MMP-8 cleavage products of LIX eluted with a linear gradient of NaCl as indicated.
###end p 115
###begin title 116
LIX is selectively cleaved by multiple MMPs.
###end title 116
###begin p 117
###xml 352 353 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</italic>
###xml 358 360 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</italic>
(A) Tris-tricine SDS-PAGE and MALDI-TOF mass spectrometry analysis of MMP processing of LIX (enzyme:substrate ratio of 1:100 (w:w)) showing that MMPs 1, 2, 8, 9 and 13 cleave LIX at position 4-5, whereas MMP-14 does not, and that only MMP-8 also cleaves at position 79approximately80. Cleavage assays of rodent MMP-8 and MMP-13 are shown in the second 8 and 13 lanes. (B) Cleavage data are summarised using the full-length sequence of LIX.
###end p 117
###begin title 118
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro cellular responses to MMP-8 cleaved LIX.
###end title 118
###begin p 119
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 451 457 <span type="species:ncbi:10090">murine</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
(A) Enhanced intracellular calcium mobilization was induced by LIX (5-92) and LIX (5-79) compared to full-length LIX (1-92) in recombinant CXCR2-expressing B300-19 cells and (B) PMNs isolated from Mmp8-/- mice (100 nM chemokine). (C) By transwell cell migration assay, both LIX (5-92) and LIX (5-79) truncated forms are more potent chemoattractants compared with the full-length LIX (1-92) for both CXCR2-expressing B300-19 cell transfectants and (D) murine PMNs isolated from either Mmp8+/+ or Mmp8-/- mice, all at 10 nM chemokine concentration.
###end p 119
###begin title 120
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
MMP-8 is required for PMN chemotaxis towards LIX in vivo, but is not required for PMN cell migration.
###end title 120
###begin p 121
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
PMN infiltration was greatly reduced in response to full-length LIX (1-92) injected into the dorsal skin air pouch of Mmp8-/- mice (black bars) compared to wild type mice (white bars). PMN numbers were calculated from myeloperoxidase assay after sacrifice at 0, 4, 8 and 12 h following injection of chemokine (n = 4). Unaltered PMN cell migration into air pouches of Mmp8-/- mice (black bars) compared to wild type mice (white bars) injected with MMP-cleaved analogues of LIX (5-92 or 5-79) reveals no intrinsic cell kinesis defects or chemotactic ability in the PMNs of the knock out mice.
###end p 121
###begin title 122
MMP processing of CXCL8 and CXCL5.
###end title 122
###begin p 123
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</italic>
###xml 256 257 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-77</italic>
###xml 550 558 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP-8 CD</italic>
###xml 717 718 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 781 782 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 872 873 864 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 901 905 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n.d.</italic>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
(A) Tris-tricine 15% SDS-PAGE gel and MALDI-TOF mass spectrometry analysis of CXCL8 cleavage products after assay with the indicated human MMPs at an enzyme to substrate ratio of 1:100. Cleavage assays of rodent MMP-8 are shown in the second 8 lane. The NH2-terminus of the CXCL8 truncated forms were deconvoluted from the mass spectrometry data and confirmed by Edman sequencing (as shown in C) with the CXCL8 forms identified shown below the corresponding gel lanes. 1-77, full-length CXCL8. (B) The effect of recombinant MMP-8 hemopexin C domain (MMP-8 CD), 10 microM EDTA, or 10 microM BB94 on CXCL8 cleavage by human MMP-8 as determined by Tris-tricine 15% SDS-PAGE and MALDI-TOF mass spectrometry. The m/z [M+H]+ of reaction products is as shown. (C) Identification of the NH2-termini of MMP cleavage products of CXCL8 and CXCL5 by MALDI-TOF mass spectrometry and NH2-terminal Edman sequencing. n.d., not determined. (D) Location of the various MMP cleavage sites on the CXCL8 and CXCL5 sequences.
###end p 123
###begin title 124
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo.</italic>
Enhanced bioactivity of MMP-truncated CXCL8 in vitro and in vivo.
###end title 124
###begin p 125
###xml 6 8 6 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">++</sup>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
(A) Ca++ ion mobilization with 10 nM CXCL8 and (B) chemotaxis of CXCR2-transfected B300-19 cells stimulated with 10 nM full-length CXCL8 (1-77) and CXCL8 (6-77) synthetic analogue of MMP-8-cleaved CXCL8. (C) Time course of air pouch PMN influx in response to CXCL8 (1-77) and CXCL8 (6-77) in Mmp8-/- mice (black) and wild type (white) mice as quantitated by myeloperoxidase assay.
###end p 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the Michael Smith Foundation for Health Research (JHC), Natural Sciences and Engineering Research Council of Canada (JHC and AES), CIHR Strategic Training Program STP-53877 (JHC and AES). CMO is a Canada Research Chair in Metalloproteinase Proteomics and Systems Biology, and has research grants from the Canadian Institutes of Health Research, the National Cancer Institute of Canada, and a Centre Grant from the Michael Smith Research Foundation (UBC Centre for Blood Research).
###end p 127

